China Universal Asset Management Co., Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$1.03 Billion
Q4 2024

A detailed history of China Universal Asset Management Co., Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 24,674 shares of REGN stock, worth $17.2 Million. This represents 1.7% of its overall portfolio holdings.

Number of Shares

24,674

Previous 14,766 67.1%

Holding current value

$17.2 Million

Previous $15.5 Million 13.23%

% of portfolio

1.7%

Previous 1.74%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	BUY	$701.85 - $1046.91 $6.95 Million - $10.4 Million	9,908 Added 67.1%	24,674 $17.6 Million
Q3 2024 Oct 25, 2024	BUY	$1024.09 - $1201.76 $5.34 Million - $6.27 Million	5,216 Added 54.62%	14,766 $15.5 Million
Q2 2024 Jul 19, 2024	SELL	$883.2 - $1071.19 $5.75 Million - $6.97 Million	-6,506 Reduced 40.52%	9,550 $10 Million
Q1 2024 Apr 29, 2024	BUY	$902.69 - $993.35 $5.2 Million - $5.72 Million	5,758 Added 55.91%	16,056 $15.5 Million
Q4 2023 May 21, 2024	SELL	$775.18 - $881.7 $4.46 Million - $5.08 Million	-5,758 Reduced 35.86%	10,298 $9.04 Million
Q4 2023 Jan 23, 2024	BUY	$775.18 - $881.7 $5.7 Million - $6.48 Million	7,351 Added 249.44%	10,298 $9.05 Million
Q3 2023 May 21, 2024	BUY	$692.45 - $844.37 $978,431 - $1.19 Million	1,413 Added 92.11%	2,947 $2.43 Million
Q3 2023 Oct 30, 2023	BUY	$692.45 - $844.37 $978,431 - $1.19 Million	1,413 Added 92.11%	2,947 $2.43 Million
Q2 2023 May 21, 2024	BUY	$700.03 - $830.35 $31,501 - $37,365	45 Added 3.02%	1,534 $1.1 Million
Q2 2023 Jul 27, 2023	BUY	$700.03 - $830.35 $31,501 - $37,365	45 Added 3.02%	1,534 $1.1 Million
Q1 2023 May 21, 2024	BUY	$680.49 - $826.97 $272,876 - $331,614	401 Added 36.86%	1,489 $1.22 Million
Q1 2023 Apr 27, 2023	BUY	$680.49 - $826.97 $272,876 - $331,614	401 Added 36.86%	1,489 $1.22 Million
Q4 2022 May 21, 2024	SELL	$705.89 - $766.39 $10.6 Million - $11.5 Million	-14,968 Reduced 93.22%	1,088 $784,000
Q4 2022 Jan 31, 2023	BUY	$705.89 - $766.39 $60,000 - $65,143	85 Added 8.47%	1,088 $785,000
Q3 2022 Oct 21, 2022	BUY	$573.97 - $724.32 $575,691 - $726,492	1,003 New	1,003 $691,000

Others Institutions Holding REGN

# of Institutions

1,493

Shares Held

85.8M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account

China Universal Asset Management Co., Ltd. Regeneron Pharmaceuticals, Inc. Transaction History